Skip to main content

Mary-Claire Roghmann, MD, MS

Academic Title:

Professor

Primary Appointment:

Epidemiology & Public Health

Secondary Appointment(s):

Medicine

Administrative Title:

Associate Dean for Physician-Scientist Training; Senior Associate Dean for Academic Advancement

Location:

10 S. Pine St., MSTF 336

Phone (Primary):

(410) 706-0062

Phone (Secondary):

(410) 706-0066

Education and Training

Dr. Roghmann received her MD from the Johns Hopkins University School of Medicine. She then completed her internal medicine residency and infectious disease fellowship at the University of Maryland Medical Center and the Baltimore VA Medical Center. She received her MS in Epidemiology and Preventive Medicine from the Department of Epidemiology and Public Health at the University of Maryland School of Medicine.

Biosketch

Dr. Roghmann is an infectious disease physician and clinical investigator. She is a Professor in the Departments of Epidemiology and Public Health and Medicine. She is Senior Associate Dean for Academic Advancement leading Appointment, Promotion and Tenure policies. She is Associate Dean for Physician Scientist Training and directs the Medical Scientist Training Program (MSTP). She is also a Research Health Scientist, GRECC Investigator and Staff Physician for the VA Maryland Health Care System. In addition, she is a member of our NIH funded Pepper Center

Research/Clinical Keywords

Antibiotic resistance, Staphylococcus aureus, Cross transmission, Acquisition, Diabetic Foot Infections, Diabetic Foot Ulcers, Prevention, Human microbiome, Clinical research, Molecular epidemiology

Highlighted Publications

Improving Outcomes for People with Diabetic Foot Complications

  1. O'Hara LM, Lydecker AD, Robinson GL, O'Hara NN, Kim JJ, Littman AJ, Schmidt BM, Addison O, Margolis DJ, Roghmann M. Understanding Patient Preferences Regarding Limb Salvage for Diabetic Foot Ulcers: A Discrete Choice Experiment. Diabetes Care 2025 Jul 3:dc250478. doi: 10.2337/dc25-0478. Online ahead of print. PMID: 40608361.
  2. Lydecker AD, Kim JJ, Robinson GL, Johnson JK, Brown CH, Petruccelli CC, Terrin ML, Margolis DJ, Roghmann M. Chlorhexidine vs routine foot washing to prevent diabetic foot ulcers: a randomized, blinded clinical trial. JAMA Netw Open 2025 Feb 3;8(2):e2460087.
  3. Robinson GL, Drumheller J, Lydecker AD, Rammling B, Dennis EA, Addison O, Prior SJ, Beamer BA, Sorkin JD, Gottlieb HD, Trent K, Roghmann M. Home-Based Exercise to Improve Functional Outcomes in Veterans With a Recently Healed Diabetic Foot Ulcer: Protocol for a Pilot Randomized Controlled Trial. JMIR Res Protoc. 2025 Sep 23;14:e71237. doi: 10.2196/71237. PMID: 40986852
  4. Kim JJ, Lydecker A, Davé R, Bork JT, Roghmann M. Diabetic Foot Infections: Local Prevalence of and Case-Control Study of Risk Factors for Methicillin- Resistant Staphylococcus aureus and Pseudomonas aeruginosa. Open Forum Infect Dis. 2020 Oct 26;7(10) PMID:33134411.
  5. Kim JJ, Littman AJ, Sorkin JD, Roghmann MC. Association Between Foot Surgery Type and Subsequent Healing in Veterans with Moderate-to-Severe Diabetic Foot Infections. Open Forum Infect Dis. 2021 Dec 24;9(2):ofab650. doi: 10.1093/ofid/ofab650. eCollection 2022 Feb.

Preventing the Transmission of Antibiotic resistant Bacteria in Nursing Homes

  1. O'Hara LM, Newman M, Lydecker AD, Robinson GL, Hong A, Boucher C, Osei P, Molloy EK, Johnson JK, Gurses AP, Jones H, Jacobs Slifka K, Roghmann M. Enhanced barrier precautions to prevent transmission of Staphylococcus aureus and Carbapenem-resistant organisms in nursing home chronic ventilator units. Infect Control Hosp Epidemiol. 2025 Aug 22:1-8. doi: 10.1017/ice.2025.10237. Online ahead of print. PMID: 40844634
  2. Mody L, Gibson KE, Cassone M, Vijayasiri G, Clement T, Snitkin E, Saint S, Krein SL, Janevic MR, Thiel J, Ridenour J, Nguyen A, Hicks O, Bej TA, El Chakhtoura NG, Min L, Galecki A, Greene T, Roghmann M, Chigurupati L, Perez F, Jump RLP. Epidemiology and transmission dynamics of multidrug-resistant organisms in nursing homes within the United States. Nat Commun. 2025 Mar 13;16(1):2487. doi: 10.1038/s41467-025-57566-3. PMID: 40082431
  3. Mayoryk S, O’Hara LM, Robinson GL, Lydecker AD, Jacobs Slifka K, Jones H, Roghmann M. Optimizing the implementation of Enhanced Barrier Precautions in community-based nursing homes. Amer J Infect Control. 2025 Jan;53(1):126-131. doi: 10.1016/j.ajic.2024.09.014. Epub 2024 Sep 20. PMID: 39307397
  4. Roghmann M, Lydecker L, Mody L, Mullins DC, Onukwugha, E. Strategies to Prevent MRSA Transmission in Community-based Nursing Homes: A Cost Analysis Infect Control Hosp Epidemiol 2016 Aug;37(8):962-6.
  5. Albrecht JS, Croft L, Morgan DJ, Roghmann Perceptions of Gown and Glove Use to Prevent Methicillin-resistant Staphylococcus aureus Transmission in Nursing Homes. J Am Med Dir Assoc. 2016 Sep 24.
  6. Blanco N, Johnson JK, Sorkin JD, Lydecker AD, Levy L, Mody L, Roghmann MC. Transmission of resistant Gram-negative bacteria to Healthcare Personnel Gowns and Gloves during Care of Residents in Community-based Nursing Facilities. Infect Control Hospital Epidemiol. 2018 Dec;39(12):1425-1430.
  7. Jackson SS, Lydecker AD, Magder LS, Roghmann MC. Development and Validation of a Clinical Prediction Rule to Predict Transmission of Methicillin-Resistant Staphylococcus aureus in Nursing Homes. Am J Epidemiol. 2019 Jan 1;188(1):214-221.
  8. Lydecker AD, Osei PA, Pineles L, Johnson JK, Meisel J, Stine OC, Magder L, Gurses AP, Hebden J, Oruc C, Mody L, Jacobs Slifka K, Stone ND, Roghmann MC. Targeted gown and glove use to prevent Staphylococcus aureus acquisition in community-based nursing homes: A pilot study. Infect Control Hosp Epidemiol. 2020 Oct 20:1-7. PMID: 33077004.

Microbiome Studies

  1. Woodworth MH, Babiker A, Prakash-Asrani R, Mehta CC, Steed DB, Ashley A, Koundakjian D, Acharya A, Grooms L, Bower CW, Suchindran DR, Trehan T, Halpin AL, Spalding Walters M, Reddy SC, Samore MH, Roghmann M, Hayden MK, Van Riel J, Burd EM, Lohsen S, Satola SW, Fridkin SK. Microbiota Transplantation Among Patients Receiving Long-Term Care: The Sentinel REACT Nonrandomized Clinical Trial. JAMA Netw Open. 2025 Jul 1;8(7):e2522740.doi:10.1001/jamanetworkopen.2025.22740.
  2. Hoffmann DE, von Rosenvinge EC, Roghmann M, Palumbo FB, McDonald D, Ravel J. The DTC microbiome testing industry needs more regulation. Science. 2024 Mar 15;383(6688):1176-1179. doi: 10.1126/science.adk4271. Epub 2024 Mar 14. PMID: 38484067.
  3. Roghmann M, Lydecker, AD, Hittle, L, DeBoy, RT, Nowak, RG, Johnson, JK, Mongodin, EF, Comparison of the Microbiota of Older Adults living in Nursing Homes and the Community. mSphere.  2017 Sep 13;2(5).
  4. Roghmann M, Lydecker AD, Langenberg P, Mongodin EF, Johnson JK. Microbiological effect of mupirocin and chlorhexidine for Staphylococcus aureus decolonization in community and nursing home based adults. Diagn Microbiol Infect Dis. 2017 Feb 13.
  5. Hoffmann D, Palumbo F, Ravel J, Roghmann M, Rowthorn V, von Rosenvinge E. Improving regulation of microbiota transplants. Science. 2017 Dec 15;358(6369):1390-1391.
  6. Roghmann M, Lydecker AD, Shardell M, DeBoy RT, Johnson JK, Zhao L, Hittle LL, Mongodin EF. Effect of mupirocin for Staphylococcus aureus decolonization on the microbiome of the nose and throat in community and nursing home dwelling adults. PLoS One. 2021 Jun 8;16(6):e0252004.

 

Additional Publication Citations

Research Interests

I study antibiotic resistant bacteria with a focus on their transmission or spread. Because of the need to develop nursing home-specific infection control polices and the longer length of stay in this setting, I partner with nursing homes. Our research studies have been translated into practice through new CDC guidance as Enhanced Barrier Precautions (EBP) for emerging MDROs such as pan-resistant bacteria. In the future, the CDC may recommend EBP for all residents with skin breakdown and medical devices in nursing homes moving away from the focus on culture-based precautions.

More recently I have focused on improving the outcomes of diabetic foot infections, a common cause of amputation in people with diabetes. We are completing a randomized clinical trial of a novel exercise regimen to improve functional outcomes after diabetic foot infection recovery. I am proud of our research program strives to develop sustainable and reproducible ways to improve the outcomes and quality of life of people at risk for antibiotic resistant infections.

Clinical Specialty Details

Dr. Roghmann is board certified in adult infectious diseases. She attends on the inpatient infectious disease consult service at the Baltimore VA Medical Center.

Awards and Affiliations

Outstanding Mentor Award (2007), Department of Epidemiology and Preventive Medicine (selected by graduate students), UM SOM

Barnett L. Cohen Award (2012), Maryland Branch of the American Society for Microbiology

Medical School Teaching Award (2013), Department of Epidemiology and Public Health, UM SOM

Alvan R. Feinstein Award (2016-2017), American College of Physicians (ACP)

Grants and Contracts

Dr. Roghmann has been funded by the National Institutes of Health (NIH), Veterans Health Administration Research and Development (VA), Agency for Health Care Research and Quality (AHRQ) and the Centers for Disease Control and Prevention (CDC).

Search for my current funding as PI in NIH Reporter under PI "Roghmann" or

Mary-Claire Roghmann (0000-0003-1063-9257) - ORCID

In the News

Roghmann, M. Infectious disease expert: here’s how to prevent another coronavirus-like tragedy at nursing homes | COMMENTARY. The Baltimore Sun. May 7, 2020.

Roghmann, M. Follow the Three C's to Reduce COVID-19 Risk. US News. June 30, 2020

Roghmann M. Here’s how to safely visit the elderly during the pandemic | COMMENTARY. The Baltimore Sun. October 15, 2020.

Coffey KC and Roghmann M. Loosen strict COVID restrictions in nursing homes; residents deserve freedom of choice | GUEST COMMENTARY. The Baltimore Sun. August 8, 2022.

Links of Interest